Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: Report of two successfully treated cases

Head and Neck

Volumn 26, Issue 9, 2004, Pages 829-831

  Alcedo, Juan Carlos ^a,c   Fábrega, José Manuel ^b   Arosemena, Juan Ramón ^c   Urrutia, Aníbal ^c  

^a Centro Hemato Oncologico Paitilla   (Panama)

^b Centro Médico Royal Center Paitilla   (Panama)

^c Instituto Oncologico Nacional   (Panama)

Author keywords

Adenoid cystic carcinoma; Imatinib mesylate

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL; IMATINIB; TYROSINE KINASE RECEPTOR;

ADENOID CYSTIC CARCINOMA; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG TARGETING; ENZYME INHIBITION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; MALE; NECK DISSECTION; POSTOPERATIVE CARE; PRIORITY JOURNAL; SALIVARY GLAND CANCER; TREATMENT OUTCOME; TUMOR VOLUME;

ANTINEOPLASTIC AGENTS; CARCINOMA, ADENOID CYSTIC; HUMANS; MALE; MIDDLE AGED; PIPERAZINES; PROTEIN-TYROSINE KINASES; PYRIMIDINES; SALIVARY GLAND NEOPLASMS; TREATMENT OUTCOME;

EID: 4344564244     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20094     Document Type: Article

References (5)

1. Penner CR, Folpe AL, Budnick SD. C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol 2002;15:687-691.
2. Jeng YM, Lin CY, Hsu HC. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 2000;154:107-111.
3. Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 1999;12:956-960.
4. Heinrich M, Blanke C, Druker B, Corless C. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002;20:1692-1703.
5. Winquist E, Lamont E, Hotte S, et al. Phase II study of imatinib mesylate in patients with adenoid cystic salivary gland carcinoma [abstract #2064]. Proceedings of the 2003 Annual Meeting of the American Society of Clinical Oncology.